Lora, Marilou A.
HRN: 25-69-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/13/2024
08/21/2024
IV
600MG
QID
INFECTEDD WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes